These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 9671546)

  • 1. Iron- and manganese-catalyzed autoxidation of dopamine in the presence of L-cysteine: possible insights into iron- and manganese-mediated dopaminergic neurotoxicity.
    Shen XM; Dryhurst G
    Chem Res Toxicol; 1998 Jul; 11(7):824-37. PubMed ID: 9671546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further insights into the influence of L-cysteine on the oxidation chemistry of dopamine: reaction pathways of potential relevance to Parkinson's disease.
    Shen XM; Dryhurst G
    Chem Res Toxicol; 1996 Jun; 9(4):751-63. PubMed ID: 8831820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidation of dopamine in the presence of cysteine: characterization of new toxic products.
    Shen XM; Zhang F; Dryhurst G
    Chem Res Toxicol; 1997 Feb; 10(2):147-55. PubMed ID: 9049425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, redox properties, in vivo formation, and neurobehavioral effects of N-acetylcysteinyl conjugates of dopamine: possible metabolites of relevance to Parkinson's disease.
    Shen XM; Xia B; Wrona MZ; Dryhurst G
    Chem Res Toxicol; 1996; 9(7):1117-26. PubMed ID: 8902266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential new insights into the molecular mechanisms of methamphetamine-induced neurodegeneration.
    Wrona MZ; Yang Z; Zhang F; Dryhurst G
    NIDA Res Monogr; 1997; 173():146-74. PubMed ID: 9260188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain mitochondria catalyze the oxidation of 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxyli c acid (DHBT-1) to intermediates that irreversibly inhibit complex I and scavenge glutathione: potential relevance to the pathogenesis of Parkinson's disease.
    Li H; Shen XM; Dryhurst G
    J Neurochem; 1998 Nov; 71(5):2049-62. PubMed ID: 9798930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of L-cysteine on the oxidation chemistry of dopamine: new reaction pathways of potential relevance to idiopathic Parkinson's disease.
    Zhang F; Dryhurst G
    J Med Chem; 1994 Apr; 37(8):1084-98. PubMed ID: 7909337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative metabolites of 5-S-cysteinyldopamine inhibit the pyruvate dehydrogenase complex.
    Li H; Dryhurst G
    J Neural Transm (Vienna); 2001; 108(12):1363-74. PubMed ID: 11810401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative metabolites of 5-S-cysteinyldopamine inhibit the alpha-ketoglutarate dehydrogenase complex: possible relevance to the pathogenesis of Parkinson's disease.
    Shen XM; Li H; Dryhurst G
    J Neural Transm (Vienna); 2000; 107(8-9):959-78. PubMed ID: 11041275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidation chemistry of (-)-norepinephrine in the presence of L-cysteine.
    Shen XM; Dryhurst G
    J Med Chem; 1996 May; 39(10):2018-29. PubMed ID: 8642560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irreversible inhibition of mitochondrial complex I by 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxyli c acid (DHBT-1): a putative nigral endotoxin of relevance to Parkinson's disease.
    Li H; Dryhurst G
    J Neurochem; 1997 Oct; 69(4):1530-41. PubMed ID: 9326282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal-catalyzed oxidation of protein-bound dopamine.
    Akagawa M; Ishii Y; Ishii T; Shibata T; Yotsu-Yamashita M; Suyama K; Uchida K
    Biochemistry; 2006 Dec; 45(50):15120-8. PubMed ID: 17154550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative metabolites of 5-S-cysteinylnorepinephrine are irreversible inhibitors of mitochondrial complex I and the alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase complexes: possible implications for neurodegenerative brain disorders.
    Xin W; Shen XM; Li H; Dryhurst G
    Chem Res Toxicol; 2000 Aug; 13(8):749-60. PubMed ID: 10956063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myoglobin modification by enzyme-generated dopamine reactive species.
    Nicolis S; Zucchelli M; Monzani E; Casella L
    Chemistry; 2008; 14(28):8661-73. PubMed ID: 18688822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of glutathione on the oxidation of 1-methyl-6-hydroxy-1,2,3,4-tetrahydro-beta-carboline: chemistry of potential relevance to the addictive and neurodegenerative consequences of ethanol use.
    Han QP; Dryhurst G
    J Med Chem; 1996 Mar; 39(7):1494-508. PubMed ID: 8691480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic evidence that cysteine reacts with dopaminoquinone via reversible adduct formation to yield 5-cysteinyl-dopamine: an important precursor of neuromelanin.
    Jameson GN; Zhang J; Jameson RF; Linert W
    Org Biomol Chem; 2004 Mar; 2(5):777-82. PubMed ID: 14985818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron-mediated generation of the neurotoxin 6-hydroxydopamine quinone by reaction of fatty acid hydroperoxides with dopamine: a possible contributory mechanism for neuronal degeneration in Parkinson's disease.
    Pezzella A; d'Ischia M; Napolitano A; Misuraca G; Prota G
    J Med Chem; 1997 Jul; 40(14):2211-6. PubMed ID: 9216840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron species-mediated dopamine oxidation, proteasome inhibition, and dopaminergic cell demise: implications for iron-related dopaminergic neuron degeneration.
    Zhou ZD; Lan YH; Tan EK; Lim TM
    Free Radic Biol Med; 2010 Dec; 49(12):1856-71. PubMed ID: 20854902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson's disease.
    Jellinger K; Linert L; Kienzl E; Herlinger E; Youdim MB
    J Neural Transm Suppl; 1995; 46():297-314. PubMed ID: 8821067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidation of serotonin by superoxide radical: implications to neurodegenerative brain disorders.
    Wrona MZ; Dryhurst G
    Chem Res Toxicol; 1998 Jun; 11(6):639-50. PubMed ID: 9625732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.